Stefania Sarno

Identification of ellagic acid as potent inhibitor of protein kinase CK2: a successful example of a virtual screening application.

Paolo Bonvini, S. Moro, L. Pinna, 2006, Journal of medicinal chemistry.

Selectivity of 4,5,6,7‐tetrabromobenzotriazole, an ATP site‐directed inhibitor of protein kinase CK2 (‘casein kinase‐2’)

S. Davies, L. Pinna, H. Reddy, 2001, FEBS letters.

The yeast cyclin-dependent kinase inhibitor Sic1 and mammalian p27Kip1 are functional homologues with a structurally conserved inhibitory domain.

Matteo Barberis, Lilia Alberghina, Piercarlo Fantucci, 2005, The Biochemical journal.

The carboxy‐terminal domain of Grp94 binds to protein kinase CK2α but not to CK2 holoenzyme

Lorenzo A. Pinna, F. Miró, N. Roher, 2001 .

The regulatory beta subunit of protein kinase CK2 contributes to the recognition of the substrate consensus sequence. A study with an eIF2 beta-derived peptide.

E. Itarte, L. Pinna, J. Vilardell, 2008, Biochemistry.

Unprecedented selectivity and structural determinants of a new class of protein kinase CK2 inhibitors in clinical trials for the treatment of cancer.

Roberto Battistutta, L. Pinna, R. Battistutta, 2011, Biochemistry.

Cross talk between protein kinase CK2 and eukaryotic translation initiation factor eIF2β subunit

Lorenzo A. Pinna, N. Roher, M. Plana, 2005, Molecular and Cellular Biochemistry.

Inspecting the structure-activity relationship of protein kinase CK2 inhibitors derived from tetrabromo-benzimidazole.

Giuseppe Zanotti, Roberto Battistutta, L. Pinna, 2005, Chemistry & biology.